Delivery Order SPE2DB20D1109-SPE2DB25FP65K
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price arrangement. The award, issued on September 23, 2025, carries a ceiling value of $16,955.15 with an ultimate completion date of September 24, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a delivery order valued at $4,148.89 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,891.76 delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count) on June 20, 2025, with completion scheduled for June 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $31,478.88 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $11,367.67. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,214.89 on September 11, 2025, for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to the company's distribution facility...
- The Defense Logistics Agency awarded a $59,873.54 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Otezla 30 mg tablets (60-count units). This firm fixed price, competitively awarded contract is non-set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the vendor's...
- The Defense Logistics Agency awarded a $37,286.30 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Otezla 30 mg on October 28, 2025, with completion targeted for October 29, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $16,775.89. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. The contract is performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,155.49 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive set-aside contract. The award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP65KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,728.96 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its extensive federal contract portfolio with the Defense Logistics Agency. The company's delivery orders under the SPE2DX prime contract demonstrate its capability to supply a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This particular delivery order for Otezla, an immunosuppressant used to treat inflammatory conditions, reflects the company's role in maintaining pharmaceutical supply chains for the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 8/27/25 |